| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 27,842 | 15,548 | 33,231 | 37,932 | | Cost of Revenue | 19,949 | 7,937 | 26,575 | 30,768 | | | Gross Profit | 7,893 | 7,611 | 6,656 | 7,164 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 3,641 | 2,539 | 3,564 | 3,452 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 4,252 | 5,072 | 3,092 | 3,712 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 60 | 2 | 3 | 25 | | Earnings Before Interest And Taxes | 4,311 | 5,074 | 3,095 | 3,732 | | Interest Expense | 940 | 892 | 784 | 866 | | Income Before Tax | 3,371 | 4,182 | 2,311 | 2,866 | | Income Tax Expense | 1,315 | 1,486 | 902 | 1,119 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 2,056 | 2,696 | 1,409 | 1,747 | | | Non-recurring Events | | Discontinued Operations | (1,057) | (3,098) |
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 999 | (402) | 1,409 | 1,747 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $999 | ($402) | $1,409 | $1,747 |
|
0.11% Nasdaq 0.00%
Income Statement
